-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, TwcTLXUdL+elL88xuWbd+1nuEQX+h69tPYOky5JrK+V/n7UMIvFjM8PXuM43QxAp mgESEyY69hQjT4B9G2kzOA== 0001104659-08-028499.txt : 20080430 0001104659-08-028499.hdr.sgml : 20080430 20080430171850 ACCESSION NUMBER: 0001104659-08-028499 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080204 FILED AS OF DATE: 20080430 DATE AS OF CHANGE: 20080430 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PHARMATHENE, INC CENTRAL INDEX KEY: 0001326190 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 202726770 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE PARK PLACE, SUITE 450 CITY: ANNAPOLIS STATE: MD ZIP: 21401 BUSINESS PHONE: 410 269 2600 MAIL ADDRESS: STREET 1: ONE PARK PLACE, SUITE 450 CITY: ANNAPOLIS STATE: MD ZIP: 21401 FORMER COMPANY: FORMER CONFORMED NAME: HEALTHCARE ACQUISITION CORP DATE OF NAME CHANGE: 20050505 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Fusco Joan CENTRAL INDEX KEY: 0001433830 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32587 FILM NUMBER: 08790849 BUSINESS ADDRESS: BUSINESS PHONE: 410-269-2555 MAIL ADDRESS: STREET 1: C/O PHARMATHENE, INC., ONE PARK PLACE STREET 2: SUITE 450 CITY: ANNAPOLIS STATE: MD ZIP: 21401 3 1 a3.xml 3 X0202 3 2008-02-04 0 0001326190 PHARMATHENE, INC PIP 0001433830 Fusco Joan C/O PHARMATHENE, INC. ONE PARK PLACE, SUITE 450 ANNAPOLIS MD 21401 0 1 0 0 Sr Vice President, Operations Common Stock, $0.0001 par value per share 17500 D Stock Option (right to buy) 3.18 2009-03-05 2018-03-05 Common Stock 157500 D The restricted stock award and option vest over a 4 year period with 25% vesting on the first anniversary of the grant date or 3/05/2009 and 25% on each anniversary date thereafter. On March 5, 2008, the date such stock options were granted and restricted stock was awarded, the closing price of the Issuer's common stock was $3.18 per share. /s/ Joan Fusco 2008-04-30 -----END PRIVACY-ENHANCED MESSAGE-----